RAC 2.92% $1.94 race oncology ltd

RACE Oncology Peer Analysis, page-18

  1. 5,128 Posts.
    lightbulb Created with Sketch. 3118
    How come you haven’t really looked ?

    The results all the way have been compelling .
    Recent months ovarian and breast cancer efficacy data , compared to standard of care treatments; as well as FTO inhibition trial , for melanoma ,with preclinical for melanoma commencing at once , has been very very positive .

    A lot of articles have been written in the past week alone .

    With more to come in the next month I’m sure .
    Last edited by Aqua65: 22/03/21
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.